查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1247460

2023-2030 年全球视网膜电图市场

Global Electroretinography Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

全球视网膜电图市场预计将实现利润丰厚的增长，到 2022 年将达到 4842 万美元，到 2030 年将达到 9352 万美元。 在预测期内（2023 年至 2030 年），该市场的复合年增长率为 7.2%。

称为视网膜电图 (ERG) 的诊断程序检查视网膜对光刺激的电反应。 除了来自视网膜胶质细胞的输入外，直接来自视网膜神经元的电流是 ERG 的来源。 ERG具有重要意义，因为它是一种在生理环境下监测视网膜功能的可靠、非侵入性方法。 ERG 通常使用角膜接触镜电极或接触角膜的细纤维电极成像。 这些电极允许眼表记录从视网膜发出的电活动。

市场动态

视网膜疾病患病率上升

随着视网膜疾病的增加，市场有望扩大。 例如，预计视网膜疾病患病率的增加将在预测期内推动市场扩张。 例如，根据国家眼科研究所的数据，有 770 万人患有糖尿病性视网膜病变。 到 2030 年，这一数字预计将增加到 1130 万。 大约 45% 的糖尿病患者有一定程度的糖尿病视网膜病变。 糖尿病性黄斑水肿是最典型的糖尿病视网膜病变（DME）。 根据 JAMA Ophthalmology，745,000 名美国人患有 DME。

例如，根据 2020 年 NCBI 的数据，40 岁以上人群的视网膜问题患病率在 5.35% 到 21.02% 之间。 虽然直到疾病晚期才出现症状，但视网膜疾病是富裕国家不可逆转失明的最常见原因。

高处理成本阻碍市场增长

市场受到阻碍，因为富裕的患者通常无法获得诊断测试。 我们使用医院数据、国家劳动力统计数据和政府报销来创建成本预测。

COVID-19 影响分析

疫情过后，全球视网膜电图市场有望大幅扩张。 随着封锁、旅行限制和企业倒闭，COVID-19 影响了各国的经济和行业。 COVID-19 问题已使多个国家的公共卫生系统负担过重，并凸显了对医疗基础设施进行长期投资的迫切需求。 随着 COVID-19 流行病的蔓延，医疗保健行业的发展预计将放缓。 由于全球对体外诊断和研发活动的需求不断增加，生命科学领域正在蓬勃发展。

但是，由于手术减少和设备采购延迟，医疗技术和成像市场的收入正在下降。 还预计在大流行之后，虚拟医生对专业人士的访问将取代亲自访问。 随着远程医疗改变医疗保健的提供方式，数字医疗将在未来几年蓬勃发展。

内容

第 1 章研究方法和范围

  • 调查方法
  • 调查目的和范围

第 2 章定义和概述

第 3 章执行摘要

  • 片段类型
  • 片段类型
  • 按应用程序摘录
  • 区域摘要

第 4 章动力学

  • 影响因子
    • 司机
      • 视网膜疾病患病率上升
      • 主要製造商推出新型号和技术进步
    • 约束因素
      • 高昂的处理成本阻碍了市场增长
    • 机会
    • 影响分析

第五章行业分析

  • 波特的五力分析
  • 供应链分析
  • 价格分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 分析
    • 在 COVID-19 情景之前
    • 当前的 COVID-19 情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 结论

第 7 章按类型

  • 全场闪光 ERG (ffERG)
  • 模式 ERG (PERG)
  • 多焦点 ERG (mfERG)

第 8 章按产品

  • 固定式ERG机
  • 便携式 ERG 设备

第 9 章按应用

  • 临床应用
  • 临床应用

第10章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第11章竞争格局

  • 竞争场景
  • 市场分析/份额分析
  • 併购分析

第12章公司简介

  • Electro-Diagnostic Imaging, Inc.
    • 公司简介
    • 按类型和说明分类的组合
    • 财务摘要
    • 主要发展
  • Roland Consult Stasche & Finger GmbH
  • Diagnosys LLC
  • Konan Medical USA, Inc.
  • CSO Italia
  • LKC Technologies, Inc
  • Welch Allyn
  • Diopsys, Inc.
  • Metrovision
  • Costruzione Strumenti Oftalmici

第13章 附录

简介目录
Product Code: HCIT1521

Market Overview

The global Electroretinography market reached US$ 48.42 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 93.52 million by 2030. The market is growing at a CAGR of 7.2% during the forecast period (2023-2030).

A diagnostic procedure called an electroretinogram (ERG) examines the retina's electrical reaction to a light stimulus. In addition to input from retinal glia, currents produced directly by retinal neurons are the source of the ERG. It's significant because the ERG is a reliable, non-invasive way to monitor retinal function in physiological settings. ERGs are frequently captured with the aid of a corneal contact lens electrode or a thin fiber electrode that is placed in contact with the cornea. These electrodes enable the ocular surface to record the electrical activity produced by the retina.

Market dynamics

Rising prevalence of retinal diseases

Market growth is predicted to increase with an increase in retinal disorders. For instance, over the forecast period, it is anticipated that the increased prevalence of retinal illnesses will fuel market expansion. For instance, 7.7 million people have diabetic retinopathy, according to the National Eye Institute. This figure is projected to rise to 11.3 million by the year 2030. Around 45% of patients with diabetes get diabetic retinopathy to some extent. Diabetic macular edema is the most typical type of diabetic retinopathy (DME). According to JAMA Ophthalmology, 745,000 Americans have DME.

For instance, according to the NCBI in 2020, the prevalence of retinal problems in persons over 40 ranges from 5.35% to 21.02%. While they are asymptomatic until the later stages of the disease, retinal diseases are the most frequent cause of irreversible blindness in affluent countries.

The high cost of treatment will hamper the growth of the market.

The market is hampered because wealthy patients typically cannot get diagnostic tests. Using hospital data, national labor statistics, and government insurance reimbursement, the cost projections were created.

COVID-19 Impact Analysis

Following the pandemic, the worldwide electroretinography market is anticipated to expand significantly. Due to lockdowns, travel restrictions, and business closures, the COVID-19 has had an impact on the economies and industries of many different nations. The COVID-19 problem has put an excessive strain on public health systems in several nations and emphasized the critical need for long-term investments in healthcare infrastructure. The healthcare sector's development is anticipated to slow as the COVID-19 pandemic spreads. The life sciences sector is thriving as a result of expanding global demand for in vitro diagnostic goods and R&D activity.

Yet, the medical technologies and imaging market is experiencing a decline in revenues as a result of fewer operations being performed and postponed or delayed equipment procurement. Also, after the pandemic, it is anticipated that virtual consultations between medical professionals will replace in-person consultations. Digital health will flourish in the years to come as telehealth transforms the way that healthcare is delivered.

Segment Analysis

The global Electroretinographymarket is segmented based type, Type, application and region.

The full-field flash ERG (ffERG) segment is anticipated to register the highest growth rate.

All through the projected period, the full-field flash ERG (ffERG) segment is anticipated to register the highest CAGR. The retina's mass response, known as the Full-field flash ERG (ffERG), is the aggregate of responses from different retinal sources. This is helpful for conditions like rod/cone dystrophies, cancer-associated retinopathy, and toxic retinopathies that cause widespread retinal impairment. It's important to note that the ffERG is ineffective for identifying tiny retinal lesions. The strength of the stimulus flash and the degree of adaptation both affect the components of the ffERG waveform and their underlying origins.

ffERG is an effective instrument to identify retinal pathology, track the level of retinal malfunction, and evaluate the effects of medical treatment on the retina in a clinical context. The examination of conditions including diabetic retinopathy, glaucoma, and retinitis pigmentosa, as well as the detection of toxic medication effects on the retina before serious, vision-threatening damage is done, have all been made possible by the use of ffERGs. The segment dominates the market because of the features.

Geographical Analysis

Rapid advancements in healthcare infrastructure drives the market

The market for electroretinography in North America is anticipated to have significant expansion over the ensuing years due to the region's high prevalence of retinal illnesses, expanding healthcare industry, and supportive governmental regulations.

For instance, around three million Americans, or 1% of the population, have glaucoma, according to the CDC 2021. This number is projected to rise as the American population ages; glaucoma is the third most common cause of blindness globally, contributing to up to 14% of the total number of blind people.

Optometrists and their colleagues will surely work to enhance and expand the range of services provided to glaucoma patients as the prevalence of the disease rises. We polled 667 optometrists in May 2021 to find out more about their methods for diagnosing, treating, and managing glaucoma. According to the respondents, 18% of their patients had glaucoma diagnoses, a disparity that only serves to highlight how crucial eyecare has become for the aging US population.

Competitive Landscape

The major global players Electro-Diagnostic Imaging, Inc., Roland Consult Stasche & Finger GmbH, Diagnosys LLC, Konan Medical USA, Inc., CSO Italia, LKC Technologies, Inc, Welch Allyn, Diopsys, Inc., Metrovision, Costruzione Strumenti Oftalmici.

Why Purchase the Report?

  • To visualize the global Electroretinography market segmentation based on Type, Product, Application and region,as well as understandkey commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of Electroretinography market-level with all segments.
  • PDF report consists of a comprehensiveanalysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key Types of all the major players.

The global Electroretinography market report would provide approximately 61 tables,62figures and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Type
  • 3.3. Snippet by Application
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising the prevalence of retinal diseases.
      • 4.1.1.2. New Type launches and technological advancements by the key players.
      • 4.1.1.3. XX
    • 4.1.2. Restraints
      • 4.1.2.1. The high cost of treatment will hamper the growth of the market.
      • 4.1.2.2. XX
    • 4.1.3. Opportunity
      • 4.1.3.1. XX
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Before COVID-19 Scenario
    • 6.1.2. Present COVID-19 Scenario
    • 6.1.3. PostCOVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Full-field flash ERG (ffERG) *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Pattern ERG (PERG)
  • 7.4. Multifocal ERG (mfERG)

8. By Product

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 8.1.2. Market Attractiveness Index, By Product
  • 8.2. Fixed ERG Machines*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Portable ERG Machines

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Clinical Application*
    • 9.2.1. Introduction
  • 9.3. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.4. Clinical Application

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Electro-Diagnostic Imaging, Inc *
    • 12.1.1. Company Overview
    • 12.1.2. Type Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Roland Consult Stasche & Finger GmbH
  • 12.3. Diagnosys LLC
  • 12.4. Konan Medical USA, Inc.
  • 12.5. CSO Italia
  • 12.6. LKC Technologies, Inc
  • 12.7. Welch Allyn
  • 12.8. Diopsys, Inc.
  • 12.9. Metrovision
  • 12.10. Costruzione Strumenti Oftalmici

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us